Scarica l'app Stockscreener
186.95
0.70%
-1.32
Dopo l'orario di chiusura:
186.95
Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie
Jazz Pharmaceuticals PLC (J7Z.HM) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
JAZZ Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
Perpetual Ltd Lowers Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC (J7Z.HM) stock price, news, quote and history - Yahoo Finance Singapore
Insider Sell: Bruce Cozadd Sells 6,000 Shares of Jazz Pharmaceuticals PLC (JAZZ) - GuruFocus
Insider Selling: Jazz Pharmaceuticals (NASDAQ:JAZZ) Director Sells 6,000 Shares of Stock - MarketBeat
Director at Jazz Pharmaceuticals (JAZZ) sells 6,000 company shares - Stock Titan
Why is Jazz (JAZZ) down 3.9% since last earnings report? - MSN
Jazz Pharmaceuticals plc (JAZZ) reports $1.2 billion Q4 revenue, beats $1.17B estimate - MSN
JAZZ Earnings History & Surprises | EPS & Revenue Results | JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) - ChartMill
Jazz Pharmaceuticals PLC (J7Z.HM) balance sheet - Yahoo Finance Singapore
Is Jazz Pharmaceuticals (JAZZ) one of the best cheap biotech stocks to buy now? - MSN
Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare Conference - aijourn.com
Jazz Pharmaceuticals plc (JAZZ) Stock Forecasts - finance.yahoo.com
Jazz Pharmaceuticals (NASDAQ: JAZZ) Form 144 shows 6,000-share sale notice - Stock Titan
Retirement Systems of Alabama Cuts Stock Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals Stock: Steady Growth in Neuroscience and Rare Diseases Drives Long-Term Value f - AD HOC NEWS
Jazz Pharmaceuticals plc (JAZZ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
JAZZ Stock Price, Quote & Chart | JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) - ChartMill
Is Jazz Pharmaceuticals (JAZZ) Pricing Reflect Its Strong 47% One Year Share Price Return - Yahoo Finance
Hennion & Walsh Asset Management Inc. Increases Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Is Jazz Pharmaceuticals (JAZZ) Still Attractive After A 47% One Year Share Price Rally - simplywall.st
Jazz projects $4.25B–$4.50B 2026 revenue while advancing rare disease and oncology launches - MSN
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Trend Review: Will Jazz Pharmaceuticals plc benefit from green energy policiesTake Profit & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Jazz Pharmaceuticals PLC $JAZZ Stock Position Reduced by Wedge Capital Management L L P NC - MarketBeat
Portfolio Recap: Is Jazz Pharmaceuticals plc a defensive stock2026 Performance Recap & Smart Swing Trading Alerts - baoquankhu1.vn
Investors Have Been Waiting to Buy the Dip in This Hot Biopharma Stock - Barchart.com
Vanguard amends Schedule 13G/A after realignment (JAZZ) - stocktitan.net
SG Americas Securities LLC Has $23.12 Million Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Its New Nutrition Alliance For Sleep Disorders - simplywall.st
JAZZ SEC FilingsJazz Pharmaceuticals Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report? - Yahoo Finance
Jazz Pharmaceuticals (NASDAQ:JAZZ) Rating Increased to Strong-Buy at Truist Financial - MarketBeat
Targets Report: Can Jazz Pharmaceuticals plc expand its profit margins2026 PostEarnings & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
MassMutual Private Wealth & Trust FSB Sells 7,073 Shares of Jazz Pharmaceuticals PLC $JAZZ - marketbeat.com
A Voice for Advocacy and Awareness in HER2+ Gastroesophageal AdenocarcinomaJazz Pharmaceuticals - Oncodaily
American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education - Lelezard
People with sleep disorders to get guidance on sodium, heart risk - Stock Titan
Is the options market predicting a spike in Jazz Pharmaceuticals stock? - MSN
How New Ziihera and JZP898 Data from AACR 2026 Will Impact Jazz Pharmaceuticals (JAZZ) Investors - simplywall.st
Groupama Asset Managment Lowers Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Narcolepsy Therapeutics Market (2025) | Central Nervous System - openPR.com
Why is Jazz Pharmaceuticals plc stock going up2026 Technical Overview & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Piper Sandler Maintains Overweight Rating for JAZZ, Raises Price Target | JAZZ Stock News - GuruFocus
Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $232.00 Price Target at Piper Sandler - marketbeat.com
Piper Sandler raises Jazz Pharmaceuticals stock price target on growth outlook - Investing.com UK
Jazz Pharmaceuticals to present clinical, preclinical data at AACR 2026 - Yahoo Finance
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):